Published in Am Ind Hyg Assoc J on February 01, 1977
Environmental and occupational exposure to benzene by analysis of breath and blood. Br J Ind Med (1988) 1.31
Lymphohaematopoietic cancer risk among chemical workers exposed to benzene. Occup Environ Med (2004) 0.94
Separation and determination of phenol, alpha-naphthol m- and p-, o-cresols and 2,5-xylenol, and catechol in the urine after mixed exposure to phenol, naphthalene, cresols, and xylenols. Br J Ind Med (1986) 0.91
Respiratory cancer and occupational exposure to arsenicals. Arch Environ Health (1974) 2.29
Mortality among individuals occupationally exposed to benzene. Arch Environ Health (1978) 1.94
Morbidity study of extruder personnel with potential exposure to brominated dioxins and furans. I. Results of blood monitoring and immunological tests. Br J Ind Med (1992) 1.60
Helicobacter pylori infection: prevalence and clinical relevance in a large company. J Occup Environ Med (1998) 1.57
Morbidity follow up study of BASF employees exposed to 2,3,7, 8-tetrachlorodibenzo-p-dioxin (TCDD) after a 1953 chemical reactor incident. Occup Environ Med (1994) 1.57
Mortality surveillance in a large chemical company: the Union Carbide Corporation experience, 1974-1983. Am J Ind Med (1990) 1.47
Vinyl chloride exposure in a controlled industrial environment. A long-term mortality experience in 594 employees. Arch Environ Health (1975) 1.33
Men assigned to ethylene oxide production or other ethylene oxide related chemical manufacturing: a mortality study. Br J Ind Med (1990) 1.19
Determinants of mortality in an industrial population. J Occup Med (1976) 1.16
A mortality survey of men engaged in the manufacture of organic dyes. J Occup Med (1983) 1.15
Cohort mortality study of chemical workers with potential exposure to the higher chlorinated dioxins. J Occup Med (1987) 1.11
Progress and prospects: gene therapy clinical trials (part 1). Gene Ther (2007) 1.09
Mortality experience of employees exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). J Occup Med (1980) 1.05
Population based mortality surveillance in carbon products manufacturing plants. Br J Ind Med (1987) 0.99
Cause specific mortality among employees engaged in the manufacture, formulation, or packaging of 2,4-dichlorophenoxyacetic acid and related salts. Br J Ind Med (1988) 0.98
Mortality among employees engaged in chemical manufacturing and related activities. Am J Epidemiol (1985) 0.98
Mortality experience of 161 employees exposed to ethylene dibromide in two production units. Br J Ind Med (1980) 0.97
Study of morbidity of personnel with potential exposure to vinclozolin. Occup Environ Med (1995) 0.97
A mortality analysis of employees engaged in the manufacture of 2,4,5-trichlorophenoxyacetic acid. J Occup Med (1980) 0.94
A mortality survey of employees engaged in the development or manufacture of styrene-based products. J Occup Med (1980) 0.91
DBCP and testicular effects in chemical workers: an epidemiological survey in Midland, Michigan. J Occup Med (1980) 0.88
Health exam findings among individuals occupationally exposed to benzene. J Occup Med (1978) 0.88
Mortality among a sample of chemical company employees. Am J Ind Med (1985) 0.87
An update of mortality due to brain neoplasms and other causes among employees of a petrochemical facility. J Occup Med (1991) 0.87
Medical and morbidity surveillance findings among employees potentially exposed to TCDD. Br J Ind Med (1983) 0.85
Correction of respiratory burst activity in X-linked chronic granulomatous cells to therapeutically relevant levels after gene transfer into bone marrow CD34+ cells. Hum Gene Ther (1998) 0.85
Cytogenetic studies in lymphocytes of workers exposed to 2,3,7,8-TCDD. Int Arch Occup Environ Health (1993) 0.84
Health evaluation of employees occupationally exposed to methylene chloride. Scand J Work Environ Health (1983) 0.84
Mortality study of ethanol and isopropanol production workers at two facilities. Scand J Work Environ Health (1992) 0.82
A health study of employees exposed to vinylidene chloride. J Occup Med (1976) 0.81
Investigation of a cluster of ten cases of Hodgkin's disease in an occupational setting. Int Arch Occup Environ Health (1996) 0.79
Carcinogenic risk assessment: ethylene dibromide. Toxicol Appl Pharmacol (1979) 0.79
[Leptospirosis after a staff outing]. Dtsch Med Wochenschr (2000) 0.78
Specific Helicobacter pylori antigens unable to distinguish nonucler dyspepsia or peptic ulcer cases from asymptomatic seropositive controls: a nested case-control study in employees of a large company. Dig Dis Sci (2000) 0.78
Gene therapy of chronic granulomatous disease. Bone Marrow Transplant (2000) 0.77
A mortality study of a research, engineering, and metal fabrication facility in western New York State. Am J Epidemiol (1988) 0.77
BASF studies: epidemiological and clinical investigations on dioxin-exposed chemical workers. Teratog Carcinog Mutagen (1998) 0.77
Diisocyanates in polyurethane plastics applications. Occup Med (2000) 0.76
Cancer incidence in the wastewater treatment plant of a large chemical company. Int Arch Occup Environ Health (2009) 0.75
Digestive tract neoplasms among employees with past exposure to brominated dioxins. Occup Environ Med (1997) 0.75
Linking industrial hygiene and health records. Am Ind Hyg Assoc J (1975) 0.75
Linking industrial hygiene and health records. J Occup Med (1977) 0.75
Mortality experience of employees with occupational exposure to DBCP. Arch Environ Health (1984) 0.75
Health of workers exposed to 1, 1, 1,-trichloroethane: a matched-pair study. Arch Environ Health (1979) 0.75
Mortality among employees chronically exposed to caustic dust. J Occup Med (1977) 0.75
A mortality evaluation of employees with potential exposure to methyl isocyanate. J Occup Med (1986) 0.75
A review of medical surveillance records of employees exposed to ethyleneamines. J Occup Med (1991) 0.75
The question of a cancer epidemic: a case study of Cherokee County, North Carolina. N C Med J (1983) 0.75